Use of zona pellucida glycoproteins for immunocontraception

Details Use of zona pellucida glycoproteins for immunocontraception Use of zona pellucida glycoproteins for immunocontraception

A - Human Necessities

61

K

A61K 39/00 (2006.01) A61K 9/127 (2006.01)

Patent

CA 2137363

A vaccine for the immunocontraception of mammals is described. The vaccine consists of zona pellucida antigens and an adjuvant encapsulated in a liposome delivery system. The liposome delivery system allows for the slow release of antigen resulting in a prolonged immune response. In particular, after a single injection of the vaccine, levels of anti-zona pellucida antibodies were detected for up to 22 months. Thus, the vaccine according to the present invention is effective after a single dose and is therefore very useful in immunocontraceptive protocols.

Affiliated with

Also associated with

Rating

Use of zona pellucida glycoproteins for immunocontraception does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Use of zona pellucida glycoproteins for immunocontraception, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Use of zona pellucida glycoproteins for immunocontraception will most certainly appreciate the feedback.

Rate now

Comments { 0 }

Profile ID: LFCA-PAI-O-1344735